trending Market Intelligence /marketintelligence/en/news-insights/trending/87L0GJpxWg4YipNmfH_5hQ2 content esgSubNav
In This List

Cellular Biomedicine board approves $10M stock repurchase program

Case Study

Identifying PPE Suppliers During the Pandemic

Blog

Highlighting the Top Regional Aftermarket Research Brokers by Sector Coverage

Video

COVID-19 Impact & Recovery: Healthcare Outlook for H2 2021

Blog

Corporate Credit Risk Trends in Developing Markets: A Loss Given Default (LGD) Perspective


Cellular Biomedicine board approves $10M stock repurchase program

The Cellular Biomedicine Group Inc. board approved a $10 million stock repurchase program.

The stocks will be repurchased through the open market.